| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.34 | 0.04 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |